-
Add to Cart The item has been addedM646361-50mgMC-VA-PAB-Exatecan is a agent-linker conjugate for ADC . MC-VA-PAB-Exatecan contains the ADC linker (peptide MC-VA-PAB) and a DNA topoisomerase I inhibitor Exatecan ( HY-13631 ). MC-VA-PAB-Exatecan synthesized ADC shows good antitumor -
Add to Cart The item has been addedM646361-5mgMC-VA-PAB-Exatecan is a agent-linker conjugate for ADC . MC-VA-PAB-Exatecan contains the ADC linker (peptide MC-VA-PAB) and a DNA topoisomerase I inhibitor Exatecan ( HY-13631 ). MC-VA-PAB-Exatecan synthesized ADC shows good antitumor -
Add to Cart The item has been addedM648353-10mgMC-VA-PABC-MMAE is a agent-linker conjugate for ADC . MC-VA-PABC-MMAE contains the ADCs linker (peptide MC-VA-PABC) and a potent tubulin polymerization inhibitor MMAE ( HY-15162 )In VitroADCs are comprised of an antibody to which is attached an ADC -
Add to Cart The item has been addedM648353-1mgMC-VA-PABC-MMAE is a agent-linker conjugate for ADC . MC-VA-PABC-MMAE contains the ADCs linker (peptide MC-VA-PABC) and a potent tubulin polymerization inhibitor MMAE ( HY-15162 )In VitroADCs are comprised of an antibody to which is attached an ADC -
Add to Cart The item has been addedM648353-5mgMC-VA-PABC-MMAE is a agent-linker conjugate for ADC . MC-VA-PABC-MMAE contains the ADCs linker (peptide MC-VA-PABC) and a potent tubulin polymerization inhibitor MMAE ( HY-15162 )In VitroADCs are comprised of an antibody to which is attached an ADC -
Add to Cart The item has been addedM651050-10mgMC-Val-Cit-PAB-Auristatin E is a agent-linker conjugate for ADC with potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: Target:Auristatin. -
Add to Cart The item has been addedM651050-1mgMC-Val-Cit-PAB-Auristatin E is a agent-linker conjugate for ADC with potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: Target:Auristatin. -
Add to Cart The item has been addedM651050-5mgMC-Val-Cit-PAB-Auristatin E is a agent-linker conjugate for ADC with potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: Target:Auristatin. -
Add to Cart The item has been addedM649702-1mgMC-Val-Cit-PAB-carfilzomib iodide is a agent-linker conjugate for ADC with potent antitumor activity by using carfilzomib (an irreversible proteasome inhibitor), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: Target:Traditional -
Add to Cart The item has been addedM648062-10mgMC-Val-Cit-PAB-duocarmycin chloride is a agent-linker conjugate for ADC with potent antitumor activity by using Duocarmycin (a DNA minor groove binding alkylating agent), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: -
Add to Cart The item has been addedM648062-5mgMC-Val-Cit-PAB-duocarmycin chloride is a agent-linker conjugate for ADC with potent antitumor activity by using Duocarmycin (a DNA minor groove binding alkylating agent), linked via the ADC linker MC-Val-Cit-PAB.Form:SolidIC50&: -
Add to Cart The item has been addedM650540-10mgMC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC. MC-Val-Cit-PAB-Exatecan is composed of a DNA topoisomerase I DX-8951 ( HY-13631 ) and a cathepsin cleavable ADC linker .In VitroADCs are comprised of an antibody to
